← Back to Healthcare

Drug Manufacturers - Specialty & Generic

Industry Overview

Stock Screener

Select filters to narrow down the 164 companies below

164 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $39.32B
Dividends 5.4%
P/E Ratio -56.9
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 4.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 11.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 3.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 2.9%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 3.4%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 4.0%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 7.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 7.8%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 2.1%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 1.3%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 2.2%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 4.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 2.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 5.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 0.7%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 3.6%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 0.1%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock
Market Cap $39.32B
Dividends 0.5%
P/E Ratio
Revenue $3.08M -43.2%
Net Income -$25.9M +570.7%
Profit Margin -842.9%
Employees 62
View Stock